@article{b522da9c5bf74ee3879d172c2af7b7fb,
title = "Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma",
abstract = "Doxorubicin is a prototypical inducer of immunogenic cell death (ICD) that sensitizes to subsequent immunotherapy by PD-1 blockade. However, this systemic drug combination fails against glioblastoma, hidden behind the blood–brain barrier (BBB). A recent work delineates a biophysical method for BBB permeabilization that yields effective preclinical effects of chemoimmunotherapy.",
keywords = "Blood-brain barrier, cancer immunotherapy, doxorubicin, immune checkpoint inhibitor, ultrasounds",
author = "Pol, {Jonathan G.} and Manuela Lizarralde-Guerrero and Andrea Checcoli and Guido Kroemer",
note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.",
year = "2024",
month = jan,
day = "1",
doi = "10.1080/2162402X.2024.2385124",
language = "English",
volume = "13",
journal = "OncoImmunology",
issn = "2162-4011",
number = "1",
}